Barely Significant
← all excerpts

Targeted Delivery of Lidocaine in Breast Cancer Cells via Zeolitic Imidazolate Framework-8 Nanoparticles.

Chemphyschem · 2025 · PMC12388163 · PMID 40556462

Europe PMCDOI
1
hedged sentence
0.0884
closest p · 1.8× alpha
0.0884
boldest claim

The sentences

showed a trendp ‐value = 0.0884so close (0.05 < p ≤ 0.1)
Intriguingly, the treatment showed a trend to decrease cells viability when compared to vehicle ( p ‐value = 0.0884) and ZIF‐8 0.01 mg mL −1 ( p ‐value = 0.0710), whereas a significant decrease was observed when compared to lidocaine 0.01 mg mL −1 (Figure 6b ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.